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Since early November 2016, the number of laboratory-
confirmed norovirus infections reported in Germany 
has been increasing steeply. Here, we report the 
detection and genetic characterisation of an emerging 
norovirus recombinant, GII.P16-GII.2. This strain was 
frequently identified as the cause of sporadic cases as 
well as outbreaks in nine federal states of Germany. 
Our findings suggest that the emergence of GII.P16-
GII.2 contributed to rising case numbers of norovirus 
gastroenteritis in Germany.
In 2016, the increase of notified norovirus cases in 
the winter season was unexpectedly strong and early 
(Figure 1) in Germany. In November 2016, 14,872 lab-
oratory-confirmed cases were reported to the national 
public health authority compared with a median of 
7,810 cases in the same month of the previous five 
years. This may be due to a new variant’s ability to 
escape herd immunity to the previously circulating 
strains. In this study, we conducted a phylogenetic 
analysis of the currently circulating norovirus strains 
in order to assess whether one or several new strains 
could be responsible for the current steep rise in noro-
virus cases.
Sample collection and molecular 
characterisation
The Consultant Laboratories (CL) and National Reference 
centre (NRC) are officially appointed and funded by the 
German Federal Ministry of Health and play a central 
role in detection and prevention of infection disease in 
Germany. The coordination of the CL and NRC is hosted 
by the Robert Koch-Institute. The CL for norovirus at 
the Robert Koch-Institute is focused on the molecular 
surveillance of viral gastroenteritis pathogens, espe-
cially noroviruses. For genotyping analysis, stool speci-
mens from norovirus-positive outbreaks were sent to 
the CL by diagnostic laboratories, physicians and local 
public health authorities. Between September and 
December 2016, 240 norovirus positive stool samples 
from patients with norovirus-associated AGE from 13 
federal states of Germany were analysed at the CL for 
noroviruses. Altogether 175 samples were associated 
with 69 outbreaks, mainly in childcare facilities (n = 39 
outbreaks) and nursing homes (n = 12 outbreaks) in 11 
of 16 federal states (Baden-Wuerttemberg, Bavaria, 
Berlin, Hesse, Lower Saxony, Mecklenburg-Western 
Pomerania, North Rhine-Westphalia, Rhineland-
Palatinate, Saxony, Schleswig-Holstein and Thuringia). 
Altogether 65 samples were from sporadic AGE and 
were sent by hospitals and diagnostics laboratories 
from six federal states (Baden-Wuerttemberg, Berlin, 
Brandenburg, Hamburg, Lower Saxony and North 
Rhine-Westphalia). 
Samples were genotyped as previously described [6] by 
phylogenetic analysis of ORF1 and ORF2 sequences. To 
determine the recombination breakpoint, 14 samples of 
the new norovirus recombinant were analysed in addi-
tion, using a newly established semi-nested RT-PCR 
spanning the 3’ end of the ORF1 and the P2 domain. 
In brief, RT-PCR reactions were performed using 
SuperScriptIII One-Step RT-PCR system Platinum TAQ 
DNA Polymerase (Thermo Fisher, Walthman MA, US) 
and primer sets NV1a (5’-ATGAATATGAATGAAGATGG-3’), 
NV1b (5’-ATGAACACAATAGAAGATGG-3’), NV348a 
(5’-GGTTRACCCARGAATCAAA-3’), NV348b 
(5’-GRTTMACCCAAGAITCAAA-3’) and NV348c 
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(5’-GRTTRACCCAIACTTCAAA-3’) for the first 
PCR (2328 bp fragment). The second PCR reac-
tion was carried out using the HotStarTaq Master 
Mix Kit (Qiagen, Hildesheim, Germany) and prim-
ers NV6 (5’-TACCACTATGATGCAGATTA-3’), NV6a 
(5’-TATCACTATGATGCTGACTA-3’), NV348a, NV348b, 
NV348c. PCR conditions were 5 min at 55 °C, 55 min at 
45 °C, 2 min at 94 °C, followed by 40 cycles of 15 s at 
94 °C, 30 s at 45 °C, 3 min at 68 °C and finally 5 min at 
68 °C. The resulting 2,274 bp amplicons were subjected 
to direct sequencing. Nucleotide sequences of these 
samples were submitted to the GenBank database with 
the accession numbers KY357449 to KY357462.
Molecular genetic results
We identified emerging recombinant norovirus strains 
previously not described in Germany in outbreaks or in 
sporadic cases of AGE. Typing results of all 240 ana-
lysed samples are shown in the Table. 
The phylogenetic analysis revealed a recombination 
of GII.P16 (ORF1) and GII.2 (ORF2) strains (Figures 
2 and 3). Using SimPlot analysis, the recombina-
tion point could be mapped to the ORF1/ORF2 junc-
tion region at nucleotide positions 732–734 (data 
not shown). The recombinant strain GII.P16-GII.2 was 
detected in 29 of 69 investigated outbreaks, in nine 
of the 11 federal states of Germany that had outbreaks 
(Baden-Wuerttemberg, Bavaria, Berlin, Hesse, Lower 
Saxony, Mecklenburg-Western Pomerania, North 
Rhine-Westphalia, Rhineland-Palatinate and Thuringia) 
and was considered as the aetiological agents in 31 
of 65 cases of sporadic AGE. The new recombinant 
was detected in specimens obtained from the spo-
radic cases in four hospitals in Berlin, North Rhine-
Westphalia, Baden-Wuerttemberg and Lower Saxony. 
Besides the new recombinant strain, the well-known 
norovirus genotypes GI.P3-GI.3 and GII.P17-GII.17 and 
the recombinant strains GII.Pe-GII.4 2012 and GII.P4 
2009-GII.4 2012 were found co-circulating, were but 
less frequently detected in the current season.
Discussion
We found a new norovirus strain GII.P16-GII.2 in sam-
ples from sporadic AGE and from norovirus outbreaks 
derived from nine federal states of Germany. It was 
recently shown that the emergence of new GII.4 noro-
virus variants can result in an increasing number of 
reported norovirus infection [5]. This has already been 
observed in Germany in the season 2007/08 which was 
Figure 1
Laboratory-confirmed norovirus infections by calendar week and year of notification, compared previous seasons, 























Data as on 24 Jan 2017.
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also characterised by an early rise and high total num-
ber of notified norovirus infections, with most of the 
analysed outbreaks caused by the new epidemic vari-
ant GII.4 2006b [7]. Another example is the emergence 
of a novel variant GII.P17-GII.17 in the season 2014/15, 
which was first genotyped in China and Japan and 
replaced the previously dominant genotype GII.Pe-GII.4 
2012 with an increased outbreak activity [8,9]. The new 
2016 GII.P16-GII.2 recombinant has sporadically been 
reported to the international molecular surveillance 
database NoroNet from Australia, Finland, France and 
Russia, and previously from Japan and China [10,11], 
suggesting a worldwide distribution.
So far, it is unclear whether the new recombinant is 
associated with more severe symptoms. Further molec-
ular and epidemiological investigations are needed to 
assess whether the emerging new recombinant noro-
virus strain GII.P16-GII.2 can replace the predominant 
GII.Pe-GII.4 2012 strain and how this will affect out-
break sizes, course of disease and herd immunity of 
the population, not only in Germany but also in other 
countries in Europe.
Figure 2
Phylogenetic analysis based on the nucleotide sequence 
of a 357 bp region (ORF1) of genogroup II norovirus, 
















































BER: Berlin; BW: Baden-Wuerttemberg; Ger: Germany; LS: Lower 
Saxony; NRW: North Rhine-Westphalia; TH: Thuringia.
Analysed sequence: nucleotide positions 4,332–4,689 according 
to accession no: AY772730. Strains analysed in this study are 
denoted with a black bullet (•). Scale bar indicates nucleotide 
substitution per site. Sequence alignments were performed with 
the ClustalW algorithm. Neighbour-joining phylogenetic tree 
was produced using the MEGA 7 software with bootstrap test 
(1,000 replicates). Bootstrap values (1,000 replicates) above 50 
are shown. The evolutionary distances were computed using the 
Kimura-2 parameter method.
Figure 3
Phylogenetic analysis based on the nucleotide sequence of 
a 628 bp region of the P2 domain (ORF2) of genogroup 










































BER: Berlin; BW: Baden-Wuerttemberg; Ger: Germany; LS: Lower 
Saxony; NRW: North Rhine-Westphalia; TH: Thuringia.
Analysed sequence: nucleotide positions 5,871–6,509 according 
to accession no: AY772730. Strains analysed in this study are 
denoted with a black bullet (•). Scale bar indicates nucleotide 
substitution per site. Sequence alignments were performed with 
the ClustalW algorithm. Neighbour-joining phylogenetic tree 
was produced using the MEGA 7 software with bootstrap test 
(1,000 replicates). Bootstrap values (1,000 replicates) above 50 
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Table
Distribution of norovirus genotypes detected in samples 
sent to the Consultant Laboratory (outbreaks vs. sporadic 
cases of acute gastroenteritis), Germany, September–
December 2016 (n = 65 samples from sporadic cases, 
n = 175 samples from 69 outbreaks)
Norovirus genotype
Sporadic cases Outbreaks
n % n % 
GI.P1-GI.1 0 0 1 1.4
GI.P3-GI.3 3 4.6 2 2.9
GI.P4-GI.4 1 1.5 3 4.3
GI.P5-GI.5 0 0 1 1.4
GI.Pb-GI.6 0 0 2 2.9
GII.P2-GII.2 1 1.5 0 0
GII.P4 2009-GII.4 2012 5 7.7 7 10.1
GII.P7-GII.6 1 1.5 4 5.8
GII.P7-GII.7 0 0 3 4.3
GII.P8-GII.8 0 0 1 1.4
GII.P16-GII.2 31 47.7 29 42.0 
GII.P16-GII.4 2012 7 10.8 7 10.1
GII.P17-GII.17 0 0 6 8.7
GII.P21-GII.3 2 3.1 1 1.4
GII.P21-GII.13 1 1.5 0 0
GII.Pe-GII.4 2012 12 18.5 2 2.9
GII.Pg-GII.1 1 1.5 0 0
Total 65 100 69 100
